Immupharma (IMM)

 

LSE:IMM: Holding(s) in Company

Immupharma

22 Mar 2017 08:51:45

Immupharma PLC

RNS Number : 1863A
Immupharma PLC
22 March 2017
 


22 MARCH 2017

 

 

 

 

NOTIFICATION OF MAJOR INTEREST BY ALTO INVEST

 

 

ImmuPharma PLC (LSE:IMM) ("ImmuPharma" or the "Company"), the specialist drug discovery and development company, announces that it has received notification by Alto Invest ("Alto") confirming its holding in ImmuPharma of 5,802,317 million Ordinary Shares in the capital of the Company, representing 4.38% of ImmuPharma's total voting rights figure of  132,522,985 Ordinary Shares.

 

Commenting, Tim McCarthy, Chairman of ImmuPharma, said: "We are delighted to be able to disclose Alto's increased holding in ImmuPharma as a further key major institutional investor which participated in our recent successful £4.1 million fundraising demonstrating its continued support for ImmuPharma."

 

Ends

 

For further information please contact:

 

ImmuPharma plc (www.immupharma.org)

+ 44 (0) 20 7152 4080

Tim McCarthy, Chairman


Lisa Baderoon, Head of Investor Relations

Twitter: @immupharma

 

+ 44 (0) 7721 413496

 

 

Northland Capital Partners Limited (NOMAD & Broker)

Patrick Claridge, David Hignell, Michael Mackintosh, Corporate Finance

Rob Rees, Corporate Broking

+44 (0)20 3861 6625








 

 

 

 

 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLVLLBLDXFZBBK